Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-2, COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04481685
What this trial is testing

A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19
University of Kansas Medical Center 20
Large-scale testing (Phase 3)Study completedNCT04425915
What this trial is testing

Efficacy of Convalescent Plasma Therapy in Patients With COVID-19

Who this might be right for
COVID
Institute of Liver and Biliary Sciences, India 400
Large-scale testing (Phase 3)UnknownNCT04460443
What this trial is testing

Sofosbuvir in Treatment of COVID 19

Who this might be right for
COVID
Tanta University 60
Not applicableStudy completedNCT04381338
What this trial is testing

Rehabilitation for People With COVID-19 in ICU

Who this might be right for
Corona Virus Disease 19 (COVID-19)COVIDAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)+1 more
University of Padova 96
Not applicableStudy completedNCT04441684
What this trial is testing

Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19)

Who this might be right for
SARS-CoV-2 Serological StatusSARS-CoV-2 Seroprevalence
University Hospital, Strasbourg, France 1,466
Not applicableStudy completedNCT04412278
What this trial is testing

Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers

Who this might be right for
COVIDIsolation, Social
Okan University 392
Testing effectiveness (Phase 2)Ended earlyNCT04441385
What this trial is testing

Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).

Who this might be right for
COVID-19
Hospital Universitario Infanta Leonor 60
Not applicableLooking for participantsNCT07545499
What this trial is testing

Physical Functions and Lifestyle Behaviours in Post-COVID-19 Syndrome Based on Circadian Rhythms

Who this might be right for
Post-COVID-19 Syndrome
Hacettepe University 50
Large-scale testing (Phase 3)Study completedNCT05021016
What this trial is testing

Study of the EpiVacCorona Vaccine With the Involvement of Volunteers Aged 60 Years and Above

Who this might be right for
Covid19
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" 150
Testing effectiveness (Phase 2)UnknownNCT04332094
What this trial is testing

Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19)

Who this might be right for
COVID-19
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 276
Not applicableStudy completedNCT04681001
What this trial is testing

Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers

Who this might be right for
Respiratory Viral InfectionCommon ColdSevere Acute Respiratory Syndrome (SARS) Pneumonia+2 more
Marinomed Biotech AG 300
Testing effectiveness (Phase 2)Ended earlyNCT04365101
What this trial is testing

Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19

Who this might be right for
CoronavirusCoronavirus InfectionSevere Acute Respiratory Syndrome Coronavirus 2+17 more
Celularity Incorporated 7
Not applicableUnknownNCT05745545
What this trial is testing

Clinical Trial of COVID-19 Vaccine（SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine） in Participants Aged 18 Years and Over

Who this might be right for
SARS-CoV-2
AIM Vaccine Co., Ltd. 3,200
Not applicableStudy completedNCT05009030
What this trial is testing

Anti-SARS-COV2 Vaccination Study in Lung Cancer Patients

Who this might be right for
Lung CancerCovid19
Fundación GECP 794
Not applicableStudy completedNCT04910607
What this trial is testing

Social and Psychological Impacts of SARS-Cov-2 Pandemic Period in the Obese Population.

Who this might be right for
ObesityCovid19
University Hospital, Bordeaux 279
Early research (Phase 1)Study completedNCT04519437
What this trial is testing

Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19

Who this might be right for
HealthyChronic Stable Illness
Regeneron Pharmaceuticals 974
Not applicableStudy completedNCT05281692
What this trial is testing

Comparison of EPM-IX to Currently Used Specimen Transportation and Extraction Devices ( CGI-EPM-IX )

Who this might be right for
SARS-CoV-2
Convergent Genomics, Inc. 205
Not applicableStudy completedNCT05458336
What this trial is testing

Controlled Clinical Trial on the Use of Saline Nasal Irrigations to Eradicate Localized Nasal Infection by SARS-CoV-2

Who this might be right for
Symptoms and Signs
University of Padova 107
Not applicableUnknownNCT04372472
What this trial is testing

SQuISH-COVID: A Pilot Study

Who this might be right for
SepsisCOVID-19
Cytovale, Inc. 300
Not applicableStudy completedNCT04782336
What this trial is testing

Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test

Who this might be right for
Covid19RSV InfectionInfluenza Type A+1 more
LumiraDx UK Limited 79
Next Page